Cas 13027-50-4,(R,R,R)-6-allyloxy-2,8-dimethyl-2-(4,8,12-trimethyl-tridecyl)-chroman

13027-50-4

Post Buying Request

Basic information

Product Name: (R,R,R)-6-allyloxy-2,8-dimethyl-2-(4,8,12-trimethyl-tridecyl)-chroman
Synonyms:
CAS NO:13027-50-4
Molecular Formula:
Molecular Weight: 442.726
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R,R,R)-6-allyloxy-2,8-dimethyl-2-(4,8,12-trimethyl-tridecyl)-chroman(CAS DataBase Reference)
NIST Chemistry Reference: (R,R,R)-6-allyloxy-2,8-dimethyl-2-(4,8,12-trimethyl-tridecyl)-chroman(13027-50-4)
EPA Substance Registry System: (R,R,R)-6-allyloxy-2,8-dimethyl-2-(4,8,12-trimethyl-tridecyl)-chroman(13027-50-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 13027-50-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

13027-50-4 Suppliers

Recommended suppliers

13027-50-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13027-50-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,2 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13027-50:
(7*1)+(6*3)+(5*0)+(4*2)+(3*7)+(2*5)+(1*0)=64
64 % 10 = 4
So 13027-50-4 is a valid CAS Registry Number.

13027-50-4Upstream product

13027-50-4Downstream Products

13027-50-4Relevant academic research and scientific papers

Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

-

Page/Page column 42-43, (2010/11/25)

Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed,

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 13027-50-4